Watch as Marjory Robertson, AVP & Senior Counsel, Sun Life U.S. and Abigail O’Connell, Senior Counsel, recap the latest 2023 leave and accommodation-related compliance developments.
The far-reaching effects musculoskeletal issues have on your employees and organization
July 11, 2023
In case you missed it, watch our webinar on musculoskeletal (MSK) issues to discover how we can help employers improve workforce wellbeing, reduce absenteeism and boost productivity.
Yes, the Pregnant Workers Fairness Act is a big deal!
May 26, 2023
Sun Life AVP & General Consul Marjory Robertson, JD talks in-depth about what the Pregnant Workers’ Fairness Act (PWFA) means for your employees, as well as steps Sun Life is taking for informing and supporting employers for this landmark federal legislation.
2023 High-cost claims and injectable drug trends analysis
May 17, 2023
For the past eleven years, Sun Life has shared our data and insights with the self-funded marketplace to help employers and brokers understand trends around the highest-cost claims.
Access to health: Will it be there when we need it?
April 06, 2023
A person's ability to access healthcare and coverage is a growing concern nationally.
Caring for our members means more than protecting their income
February 16, 2023
Sheila Sokolski, AVP, Product Management at Sun Life, shares how the behavioral health partnership with AbleTo has exceeded expectations in supporting and accommodating members by bringing care to members when they need it most, after being approved out on a disability claim for cancer.
2022 Year in Review Compliance Update Webinar
February 07, 2023
Sun Life U.S. AVP and Senior Counsel, Marjory Robertson, and Senior Counsel, Abigail O’Connell provided a recap of legal and compliance developments in 2022 related to leave and accommodation management, including a review of statutory changes and caselaw learnings as well as an overview of absence management compliance issues trending in 2023.
Introduction to Gene Therapies (3rd edition)
February 06, 2023
Learn more about recently approved Hemgenix in the treatment of Hemophilia B, the gene therapy pipeline, the approval process, and what gene therapies are, in our second edition of the Introduction to Gene Therapies paper.
Breast Cancer and COVID: Impacts of diagnosis delays
January 31, 2023
With COVID-19 slowing down preventative/diagnostic screenings, the severity of diagnosed cancer could be impacted well into the future - and for conditions like breast cancer with nearly 300,000 women being diagnosed in the U.S. in 2022 alone, this could have a big impact.
Group insurance policies are underwritten by Sun Life Assurance Company of Canada (Wellesley Hills, MA) in all states, except New York. In New York group insurance policies are issued by Sun Life and Health Insurance Company (U.S.) (Lansing, MI). Product offerings may not be available in all states and may vary depending on state laws and regulations.